What does Unlearn.AI do?
Unlearn.AI provides an AI-driven platform to streamline clinical trials using digital twins of patients. It integrates evidence, modeling, and reasoning to help trial teams make decisions with confidence. Measured traffic data covers May 1, 2026 to July 31, 2026.
What problem does Unlearn.AI solve?
Unlearn.AI addresses the challenge of making high-stakes decisions in clinical trials across fragmented data and tools. Its platform powers clarity in clinical development by connecting trial planning, monitoring, and analysis. Measured traffic data covers May 1, 2026 to July 31, 2026.
What features does Unlearn.AI offer?
Unlearn.AI offers a connected platform with features like Trial Planning and Simulations, Scout for literature search, Hindsight for exploring real-world datasets, SimLab for comparing trial scenarios, and Advanced Trial Monitoring. Measured traffic data covers May 1, 2026 to July 31, 2026.
What results does Unlearn.AI deliver?
Unlearn.AI reports real-world results including a 33% reduction in control arm size and saving over 4 months in enrollment time. The platform also claims a 20% sample size reduction and $250K per patient program savings in planning. Measured traffic data covers May 1, 2026 to July 31, 2026.
Who is Unlearn.AI for?
The product is for clinical development teams in neuroscience, immunology, metabolic disease, and other therapeutic areas. It helps expert teams across institutions streamline their trial processes. Measured traffic data covers May 1, 2026 to July 31, 2026.
What is Unlearn.AI?
Unlearn.AI is an AI-driven clinical trial platform that uses digital twins and data analysis to streamline clinical development. It is categorized under Research & Analysis. Measured traffic data covers May 1, 2026 to July 31, 2026.